« Previous
Next »
Digestive and Liver Disease
Volume 43, Issue 2
, Pages 102-109
, February 2011
Health-related quality of life is impaired in active collagenous colitis
References
- . ‘Collagenous colitis’ with watery diarrhea. A new entity. Pathol Eur. 1976;11:87–89
- Diagnosis and management of microscopic colitis. World J Gastroenterol. 2008;14:7280–7288
- Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathological findings in 15 patients. Hum Pathol. 1987;18:839–848
- Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996;39:846–851
- Microscopic colitis: a common diarrheal disease. An epidemiological study in Örebro, Sweden, 1993–1998. Gut. 2004;53:346–350
- Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122–1128
- The epidemiology of microscopic colitis: a population-based study in Olmsted County, Minnesota. Gut. 2007;56:504–508
- Meta-analysis: budesonide treatment for collagenous colitis. Aliment Pharmacol Therap. 2004;20:745–749
- . Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2008;CD003575
- Budesonide treatment of collagenous colitis: a randomized, double blind, placebo controlled trial with morphometric analysis. Gut. 2003;52:248–251
- Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 2002;123:978–984
- Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Therap. 2005;22:1115–1119
- Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo controlled trial. Gut. 2009;58:68–72
- Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorect Dis. 2005;20:312–316
- Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008;135:1510–1516
- . The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–481
- The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care. 1992;30(Suppl.):MS253–MS265
- . The MOS 36-item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263
- . The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J editor. Assessment of quality of life in clinical trials of cardiovascular therapies. USA: Le Jacq Publishing Inc.; 1984;p. 170–183
- A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804–810
- Quality of life: a valid and reliable measure of the therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 1994;106:287–296
- The Rating Form of IBD Patient Concerns: a new measure of health status. Psychosom Med. 1991;53:701–712
- . SF-36 Hälsoenkät: Svensk manual och tolkningsguide [Swedish manual and interpretation guide]. Gothenburg: Sahlgrenska University Hospital; 1994;
- . Evaluation of quality of life in clinical trials: selecting quality of life measures. Control Clin Trials. 1991;12:S204–216
- Validation of the inflammatory bowel disease questionnaire (IBDQ) in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36:77–85
- Evaluation of the inflammatory bowel disease questionnaire in Swedish patients with Crohn's disease. Scand J Gastroenterol. 2006;41:934–943
- Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997;32:1235–1240
- Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis. 2009;15:1875–1881
- . The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998;51:1105–1113
PII: S1590-8658(10)00210-0
doi: 10.1016/j.dld.2010.06.004
« Previous
Next »
Digestive and Liver Disease
Volume 43, Issue 2
, Pages 102-109
, February 2011
